Blog posts

What future for labelling regulations? 

To put it briefly: none of us knows! As the UK prepares to leave the EU, members of the Westmister Parliament voted this summer to maintain a close relationship with the EU's r…Read more.

European Commission reports on package leaflets, SmPCs

The European Commission has issued its report on the shortcomings of the Package Leaflet and Summary of Product Characteristics - at last!  The long-awaited report, which h…Read more.

Involving Users in Developing Health Information (PIF)

Involving Users in Developing Health Information was an event organised in London in May 2017 by Patient Information Forum (PIF). Our own Emily Newsom-Davis gave a talk abo…Read more.

Information Design Handbook

We are proud to be contributors to this authoritative reference book. Many in the Consumation team contributed to the pro bono experimental research that is documented he…Read more.

Commission omission - an update

This is an update to our previous post.  The Commission’s Pharmaceutical Committee discussed the NIVEL reports in October 2015. The notes of that meeting are availabl…Read more.

Talking in Turkey

Consumation has completed a collaborative project with two workshops at Medipol University in Istanbul. These were given to support health ministry requirements for&…Read more.

Is it us or is it them? Health literacy

Two things we at Consumation all share: a devotion to the users of medicines; and making information for them as clear as it can be. Consumation director David Dickinson was part o…Read more.

Scanning the regulatory horizon 2013

After two meetings in 2012, and a pan-European survey in spring of 2013, we have signposts for the way European labelling is heading.  The options included summary headlines, …Read more.

Avoiding deviations

Also of interest to QRD are the deviations between leaflets on the market and those user tested. In a retrospective review of all 2011’s marketing authorisation applications,…Read more.

Commission omission

Medicines information in the EU may look different in the near future, but only after we see the European Commission’s long-awaited research paper on the shortcomings of prod…Read more.

FDA plans new patient medication information (PMI)

Announced to a mainly industry audience of the Drug Information Association in Washington, autumn 2012, the US Food and Drug Authority plans a "new paradigm" in patient i…Read more.

E-leaflets are our future

At meetings in 2012 and 2013 it became clear that the possibilities of electronic labelling (e-labelling) are sparking the EMA's interest (and QRD's). Although paper inform…Read more.

The Pharma Packaging and Labelling Conference

In Rome in 2012, some consensus was built in a couple of days. The Pharma Packaging and Labelling Conference organised by Fleming Europe, attacked the issues facing the industry wi…Read more.

Designing information before designers: print for everyday life in the 19th century

This January 2010 event took place at the St Bride Foundation, off Fleet Street in London – an area steeped in print history. Reading University researchers Paul Stiff, Paul …Read more.